Corvus Pharmaceuticals
CRVS
CRVS
43 hedge funds and large institutions have $43.6M invested in Corvus Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.23% less ownership
Funds ownership: 70.66% → 70.43% (-0.23%)
61% less capital invested
Capital invested by funds: $113M → $43.6M (-$69.5M)
Holders
43
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
1 | +$1.12M | |
2 | +$489K | |
3 | +$105K | |
4 |
Citadel Advisors
Miami,
Florida
|
+$95K |
5 |
Russell Investments Group
London,
United Kingdom
|
+$63K |
Top Sellers
1 | -$3.52M | |
2 | -$816K | |
3 | -$431K | |
4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$263K |
5 |
ECM
ExodusPoint Capital Management
New York
|
-$124K |